Lumea, AIRA Matrix, and Acupath have Partnered to Provide a Diagnostic AI Solution for the URO17® Bladder Cancer Biomarker
March 21, 20250
LEHI, UT, UNITED STATES, March 20, 2025 /EINPresswire.com/ — Lumea, a leader in digital pathology solutions. AIRA Matrix Private Limited, an innovative technology company for AI-based diagnostic, prognostic, and predictive applications in cancer care. Acupath, a leading provider of sub-specialized anatomic and molecular pathology services. These companies have joined forces to deliver an AI-based solution to...
